跳至主要内容
临床试验/NCT00911924
NCT00911924已完成4 期

A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma

Glaukos Corporation25 个研究点 分布在 6 个国家目标入组 112 人开始时间: 2009年5月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
112
试验地点
25
主要终点
IOP 18 mm Hg or less with or without medications

研究概览

简要总结

Prospective, unmasked, evaluation of the iStent in patients that have primary open-angle glaucoma (OAG). Stent implantation in one eye will be used for analysis, with medication added at 6 months, as required.

详细描述

One hundred patients will be enrolled in the study at up to 21 sites; follow-up is through 1 year.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of primary open-angle glaucoma
  • Male or female at least 18 years of age and able to provide written informed consent
  • Mean IOP (at baseline visit after washout of any medications) must be at least 22 mm Hg and no greater than 38 mm Hg
  • Likely to be available and willing to attend follow-up visits

排除标准

  • Angle closure glaucoma
  • Secondary glaucomas
  • Prior glaucoma procedures
  • Elevated episcleral venous pressure from history of active thyroid orbitopathy, carotid-cavernous fistula, orbital tumors, or orbital congestive disease

结局指标

主要结局

IOP 18 mm Hg or less with or without medications

时间窗: 12 months

IOP 18 mm Hg or less without medications

时间窗: At 6 months

次要结局

  • Mean IOP(12 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (25)

Loading locations...

相似试验

A Prospective, Unmasked Evaluation of the iStent in... | 临床试验